Using a combination of genetics, systems biology, molecular biology, and animal models (mouse and drosophila) we have identified several signaling pathways and molecules leading to this imbalance in neurons and glial cells, including APP, Caspase-2, EphA1, and Ube3A. We are actively developing novel tools and models to validate their involvement and to investigate their potential as therapeutic targets.